DRG Epidemiology’s coverage of chronic fatigue syndrome (CFS) comprises epidemiological estimates of key patient populations across the mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan), as well as many other European countries. We report the prevalence of CFS for each country, as well as annualized case counts projected to the national population.
DRG Epidemiology’s CFS forecast will answer the following questions:
Of all people with CFS, how many in each country have been formally diagnosed?
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of CFS over the forecast period?
How many people with diagnosed CFS also have fibromyalgia?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
DRG Epidemiology provides at least ten years of forecast data for the following CFS patient populations:
Total Prevalence of Chronic Fatigue Syndrome per 1,000 Adults in 2021 and 2041tttttttttttttttt
Relative Sizes of the Factors Contributing to the Trend in Total Prevalent Cases of Chronic Fatigue Syndrome Over the Next 20 Yearsttttttttt
Epidemiology Data
Methods
Total Prevalent Cases
Total Prevalent Cases With Pain in Two or More Joints
Total Prevalent Cases With Muscle Pain
Diagnosed Prevalent Cases
Diagnosed Prevalent Cases With Fibromyalgia
Reference Materials
Literature Review
Studies Included in the Analysis of Chronic Fatigue Syndrome
Studies Excluded from the Analysis of Chronic Fatigue Syndrome
Risk/Protective Factors
Risk/Protective Factors for Chronic Fatigue Syndrome
Bibliography
Abbreviations
Glossary
Mariam Sophia
Mariam Sophia, B.D.S., M.P.H.,is an associate epidemiologist at Clarivate. Prior to studying epidemiology, she worked in a private clinical practice and later as a tutor at Manipal College of Dental Sciences. She has experience working in COVID-19 care centers and in Tele ICU. She holds an M.P.H. from India’s Manipal University, where she specialized in epidemiology, and a B.D.S. from India’s Yenepoya University. Her research thesis assessed the nutritional status of tribal children less than five years old. She was also an intern in the government-run tuberculosis program (RNTCP).
Mudasir Khan, M.P.H.
Mudasir Khan, M.P.H., is a senior epidemiologist at Clarivate. His areas of expertise are oncology and psychiatry diseases. He holds a master’s degree in public health from the Tata Institute of Social Sciences in Mumbai.
